Found 335 matching trials
Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia N/A This laboratory study is looking into biomarkers in samples from younger pa...
Show More Location
Children's Oncology Group
Learn More & Join Trial
Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation PHASE1 This is a phase I single center dose escalation study with an extension at ...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Lenalidomide, Adriamycin, Dexamethasone (RAD) Versus Lenalidomide, Bortezomib, Dexamethasone (VRD) for Induction in Newly Diagnosed Multiple Myeloma Followed by Response-adapted Consolidation and Lenalidomide Maintenance PHASE3 The investigators propose this study utilizing Lenalidomide, Adriamycin, De...
Show More Location
Universitätsklinikum Aachen, Med. Klinik IV, Hämatologie u. Onkologie
Learn More & Join Trial
Allo HSCT Using RIC for Hematological Diseases PHASE2 This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Easy-to-Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials (BMT CTN 1205) NA The study has two parts: (1) Randomized Study to evaluate the effectiveness...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma PHASE1 This phase I trial studies the side effects and best dose of genetically mo...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Mechanism of Allogeneic UCB Therapy in Cerebral Palsy PHASE1 In our prior study on the therapeutic mechanism of UCB, changes in cytokine...
Show More Location
CHA Bundang Medical Center
Learn More & Join Trial
Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial PHASE4 This study aims to determine whether the recurrence rate of high-risk acute...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation PHASE2 This is a prospective, single-arm, phase II study. Patients will be treated...
Show More Location
Chao Family Comprehensive Cancer Center, University of California Irvine
Learn More & Join Trial
Busulfan and Cyclophosphamide Followed By ALLO BMT NA This is a treatment guideline to allow routine clinical data to be collecte...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial